Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$700,467
+$225,866 QoQ
Shares Held
584
+13.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#3,453
of 4,605 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICUS CAPITAL holds $5,105,271 across 9 Drug Manufacturers - General names. LLY ranks #4 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,876 | $1,238,357 | |
| 2 | ABBV |
AbbVie Inc.
|
3,138 | $789,646 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,836 | $749,926 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
584 | $700,467 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,416 | $431,577 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,303 | $363,178 | |
| 7 | NVS |
Novartis AG
|
2,251 | $352,776 | |
| 8 | AMGN |
Amgen Inc
|
716 | $259,277 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $700,467 | 584 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $474,601 | 516 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $504,024 | 469 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $315,882 | 414 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $297,000 | 381 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $423,691 | 513 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $423,056 | 548 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $393,357 | 444 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $746,938 | 825 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $669,823 | 861 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $318,857 | 547 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $524,776 | 977 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $256,532 | 547 | Shares | Sole | 2023-08-17 | |
| 2022-12-31 | $250,234 | 684 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $305,565 | 945 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $256,141 | 790 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $202,463 | 707 | Shares | Sole | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||